<DOC>
	<DOC>NCT01088568</DOC>
	<brief_summary>The objective is to conduct a contralateral prospective clinical study to compare the safety, efficacy, and quality of vision of the STAAR Surgical Co. Toric Implantable Contact Lens TICL) versus Custom Laser Vision Correction (Q-LASIK) in human eyes for the correction of myopia with astigmatism.</brief_summary>
	<brief_title>Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism</brief_title>
	<detailed_description />
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Age: 2145 years old Documented stable refraction for at least 1 year (3.0 to 8.0D of myopia with 1.0 to 4.0D of astigmatism or SE from 3.5 to 10D BSCVA: 20/20 or better Pupil diameter: smaller than 7mm under mesopic condition Contact lens discontinued 3 weeks and 1 week for hard and soft wearers respectively Evidence of progressive or acute disease Evidence of connective tissue disease or clinically significant atopic disease ACD less than 2.8mm from endothelium ECC less than 2200 cells/mm2 Narrow angle of anterior chamber Residual stromal thickness less than 280 microns</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Keratomileusis, laser in situ</keyword>
	<keyword>Phakic Intraocular Lenses</keyword>
	<keyword>myopia</keyword>
	<keyword>astigmatism</keyword>
	<keyword>Implantable Collamer Lens, Toric</keyword>
</DOC>